Max Robotics — Global Service Robot Directory + US Certification

About

Joel B. Nelson is a leading urologic oncologist whose research has fundamentally shaped the understanding of prostate cancer treatment, particularly the economics and outcomes of radical prostatectomy. His work centers on the comparative effectiveness and cost analysis of surgical approaches, including open, laparoscopic, and robotic-assisted techniques. Nelson’s seminal 2012 systematic review on the costs of radical prostatectomy, cited over 110 times, remains a cornerstone for healthcare policy and hospital decision-making. He further advanced the field with a landmark cost-analysis comparing open and robotic-assisted procedures, demonstrating the financial implications of technological adoption. Nelson has also been a prominent voice in the ongoing debate over surgical approaches, contributing to a highly cited 2007 discussion that helped frame the conversation around open versus minimally invasive surgery. His later work explores the persistent challenge of post-surgical urinary incontinence and the evolving role of stereotactic body radiation therapy in prostate cancer treatment patterns. Through his rigorous, evidence-based analyses, Nelson has provided critical insights that guide both clinical practice and healthcare resource allocation, making him an essential figure in the modern management of prostate cancer.